Search Results for "Ncs Diagnostics Inc Canada"

07:37 EST 6th March 2015 | BioPortfolio

Matching Channels

Roche

Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009. The pharmaceutical products of Roche are major players in the followin...

Hepatitis B Immune Globulin Cangene

HepaGam B® [Hepatitis B Immune Globulin (Human) Injection] contains purified antibodies specific for the hepatitis B surface antigen (HBsAg). * It is approved in Canada and the United States f...

Alto Marketing - specialist healthcare and life science communications consultancy

Alto Marketing is a committed and forward-thinking specialist healthcare and life science communications consultancy.  With extensive experience of worldwide marketing in sectors including (...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Cambridge

In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...

Matching News

Miacom diagnostics receives Health Canada approval for hemoFISH assays

Germany-based Miacom diagnostics has received approval from the Health Canada for its hemoFISH assays, which are designed to help identify and differentiate bacterial pathogens from positive blood cul...

Valeant buys NicOx’ US ophthalmic diagnostics unit

Ophthalmology-focused French biotech firm NicOx says that Canada’s Valeant Pharmaceuticals International has acquired NicOx' US diagnostics subsidiary NicOx Inc.

People on the move (week of September 22)

A bi-weekly roundup of People on the move in Canada’s life science and biotech sectors. Proteocyte Diagnostics announces the appointment of Dr. Mario Thomas to the role of president. With over 25 ye...

Roche buys Ariosa Diagnostics

Roche has purchased the privately-held US company Ariosa Diagnostics for an undisclosed fee as it looks to expand further into other markets. Californian-based Ariosa is a molecular diagnostics firm t...

WOUNDCHEK™ Laboratories receives market clearance for WOUNDCHEK™ Protease Status in Canada

WOUNDCHEK™ Laboratories announced today that it has received market clearance from Health Canada for WOUNDCHEK™ Protease Status, the world’s first point of care

Bill & Melinda Gates Foundation awards grant to Fio for Ebola diagnostics

Fio has received a grant financed by the Bill & Melinda Gates Foundation to adapt its Fionet solution to connect rapid diagnostics and data in the fight against Ebola. Headquartered in Toronto, Cana...

AstraZeneca and Pfizer Canada team with Contextual Genomics on personalized medicine initiative

Mississauga, ON and Vancouver, BC – AstraZeneca and Pfizer Canada are teaming up with molecular diagnostics company Contextual Genomics and the Personalized Medicine Initiative (PMI) on the National...

Diagnostics Development Hub to boost biomedical research in Singapore

Singapore's biomedical research sector received a major boost with the launch of a new Diagnostics Development (DxD) Hub. The DxD Hub aims to develop medical diagnostics as one part of the medical tec...

Matching PubMed Articles

Current situation and challenges in companion diagnostics development.

The personalized health care, it is defined as a medical care which provide the optimal therapy for each individual in consideration of a patient's individual difference, such as a genetic background ...

Clinician's Commentary on Dawes et al.(1.).

Clinician's Commentary on Vermeltfoort et al.(1.).

Clinician's Commentary on Rodrigues et al.(1.).

Clinician's Commentary on Cupido et al.(1.).

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement